Dr. Fahad S Gilani
Claim this profileCatholic Medical Center
Studies Aortic Valve Stenosis
Studies Aortic Stenosis
3 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Fahad S Gilani is currently running
TAVR
for Aortic Stenosis
Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.
Recruiting1 award N/A3 criteria
Proteomics Analysis
for Heart Valve Disease
The purpose of the HALT Biomarkers study are to identify a panel of circulating proteins that discriminates between patients with and without Hypo-Attenuated Leaflet Thickening (HALT) and can be used to supplement the diagnosis of HALT; to characterize changes in circulating proteins after treatment of HALT with systemic anticoagulation; and to identify circulating proteins that predict the occurrence of HALT. The study population will be adult patients undergoing transfemoral transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS) or bioprosthetic valve degeneration. Enrollment will continue until 30 patients with HALT are identified for completion of phase 1. Based on a HALT incidence rate of 10%, we anticipate enrolling 300 patients. Patients are enrolled prior to undergoing transfemoral TAVR. Blood samples, clinical data and echocardiograms will be collected at the following timepoints: baseline (pre-TAVR, T0), post-TAVR (pre-discharge, T1), 30-day follow-up (window 3-9 weeks, T2), and 6-month follow-up (T3). Cardiac 4D CT will be performed at the 30-day follow-up visit to screen for the occurrence of HALT. Patients with HALT will be treated with systemic anticoagulation for 5-6 months, at which point a follow-up CT scan and blood sample will be obtained. Control subjects will also undergo a 6-month study visit with blood sample collection. The study will be conducted within two phases. Phase 1 will serve as a derivation / discovery study in which candidate protein biomarkers of HALT will be identified. Once this is successfully completed, a second cohort will be enrolled within phase 2. Phase 2 will be performed under the auspices a future contract or amendment and will seek to cross-validate the initial study findings.
Recruiting1 award Phase 13 criteria
More about Fahad S Gilani
Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Fahad S Gilani has experience with
- Proteomics Analysis
- Tendyne Mitral Valve System
- MitraClip System
- Medtronic Evolut PRO+ TAVR System
- Evolut FX TAVR System
Breakdown of trials Fahad S Gilani has run
Aortic Valve Stenosis
Aortic Stenosis
Hypoattenuated Leaflet Thickening
Bioprosthetic Valve Degeneration
Valvular Heart Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Fahad S Gilani specialize in?
Fahad S Gilani focuses on Aortic Valve Stenosis and Aortic Stenosis. In particular, much of their work with Aortic Valve Stenosis has involved treating patients, or patients who are undergoing treatment.
Is Fahad S Gilani currently recruiting for clinical trials?
Yes, Fahad S Gilani is currently recruiting for 3 clinical trials in Manchester New Hampshire. If you're interested in participating, you should apply.
Are there any treatments that Fahad S Gilani has studied deeply?
Yes, Fahad S Gilani has studied treatments such as Proteomics Analysis, Tendyne Mitral Valve System, MitraClip System.
What is the best way to schedule an appointment with Fahad S Gilani?
Apply for one of the trials that Fahad S Gilani is conducting.
What is the office address of Fahad S Gilani?
The office of Fahad S Gilani is located at: Catholic Medical Center, Manchester, New Hampshire 03103 United States. This is the address for their practice at the Catholic Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.